Development and Content Validation of the Childhood Early Oral Aging Syndrome (CEOAS) Index for the Deciduous Dentition
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Aging
- Sponsor
- University of Nove de Julho
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Development of CEOAS index
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Premature, non-physiological tooth wear in childhood has numerous repercussions for oral health. This is a growing problem with multifactorial causes and associated with the current lifestyle. The aim of the present study was the development and determination of content validity of the Childhood Early Oral Aging Syndrome (CEOAS) index for the primary dentition as a diagnostic and epidemiological survey tool considering the current changes found in this population.
Investigators
Sandra Kalil Bussadori
Principal Investigator
University of Nove de Julho
Eligibility Criteria
Inclusion Criteria
- •Dental surgeons
Exclusion Criteria
- •Other healthcare professionals
Outcomes
Primary Outcomes
Development of CEOAS index
Time Frame: Immediately
The Childhood Early Oral Aging Syndrome index will be to investigate clinical signs and symptoms related to the early loss of dental structure associated with the most prevalent enamel defects, which significantly contribute to oral aging. The clinical management of tooth wear is also addressed in CEOAS scores 1, 2 and 3. Current indices used for non-carious conditions do not enable the concomitant investigation of enamel defects, which makes the proposed index innovative and of extreme important to epidemiological surveys. Understanding the prevalence of factors that either separately or synergically accelerate the process of early aging is useful to the establishment of novel treatment strategies. The CEOAS index involves scores of 0 to 3 for the assessment of tooth wear and dental management, whereas scores of I, II and III are used concomitantly in cases of the presence of enamel defects, as show in Table 1
Secondary Outcomes
- Validation of CEOAS index(Immediately)